Home › NDC Lookup › RxCUI directory › RxCUI 199241

Activated charcoal 104 MG/ML Oral Suspension — RxCUI 199241

RxNorm drug concept · Semantic clinical drug
RxCUI 199241 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI199241
Official nameActivated charcoal 104 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asactivated charcoal 25 GM per 240 ML Oral Suspension
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Activated charcoal 104 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Activated charcoal 104 MG/ML Oral Suspension RxCUI 199241

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Activated charcoal 272
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Insta-Char 217743
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Activated charcoal Oral Suspension 226681
    • Activated charcoal Oral Liquid Product 1153454
    • Activated charcoal Oral Product 1153455
    • Activated charcoal Oral Suspension [Insta-Char] 365856
    • Insta-Char Oral Liquid Product 1173419
    • Insta-Char Oral Product 1173420
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Activated charcoal 104 MG/ML SCDC · 330608
  • Activated charcoal Oral Suspension SCDF · 226681
  • Activated charcoal Oral Liquid Product SCDG · 1153454
  • Activated charcoal Oral Product SCDG · 1153455

Brand-Name Concepts

  • Activated charcoal 104 MG/ML Oral Suspension [Insta-Char] SBD · 2699484
  • Activated charcoal 104 MG/ML [Insta-Char] SBDC · 2699483
  • Activated charcoal Oral Suspension [Insta-Char] SBDF · 365856
  • Insta-Char Oral Liquid Product SBDG · 1173419
  • Insta-Char Oral Product SBDG · 1173420
  • Insta-Char BN · 217743

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 199241 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
66689-0113-08 240 mL in 1 BOTTLE, PLASTIC (66689-113-08) INSTA-CHAR AQUEOUS VistaPharm, LLC 2024-12-13
66689-0114-08 240 mL in 1 BOTTLE, PLASTIC (66689-114-08) INSTA-CHAR AQUEOUS VistaPharm, LLC 2024-12-13
66689-0115-08 240 mL in 1 BOTTLE, PLASTIC (66689-115-08) INSTA-CHAR SORBITOL VistaPharm, LLC 2024-12-13
Observed labelers: VistaPharm, LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.